Raphael Campeas

5.4k total citations
52 papers, 3.8k citations indexed

About

Raphael Campeas is a scholar working on Experimental and Cognitive Psychology, Clinical Psychology and Psychiatry and Mental health. According to data from OpenAlex, Raphael Campeas has authored 52 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Experimental and Cognitive Psychology, 38 papers in Clinical Psychology and 11 papers in Psychiatry and Mental health. Recurrent topics in Raphael Campeas's work include Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (40 papers), Child and Adolescent Psychosocial and Emotional Development (17 papers) and Obsessive-Compulsive Spectrum Disorders (15 papers). Raphael Campeas is often cited by papers focused on Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (40 papers), Child and Adolescent Psychosocial and Emotional Development (17 papers) and Obsessive-Compulsive Spectrum Disorders (15 papers). Raphael Campeas collaborates with scholars based in United States, Israel and Canada. Raphael Campeas's co-authors include Michael R. Liebowitz, Franklin R. Schneier, Brian A. Fallon, Abby J. Fyer, Sharon Davies, Jack M. Gorman, Deborah Goetz, Donald F. Klein, Andrew Levin and Eric Hollander and has published in prestigious journals such as Proceedings of the National Academy of Sciences, American Journal of Psychiatry and Biological Psychiatry.

In The Last Decade

Raphael Campeas

52 papers receiving 3.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raphael Campeas United States 30 2.6k 2.5k 695 583 454 52 3.8k
Sharon Davies United States 25 2.0k 0.8× 1.7k 0.7× 887 1.3× 1.2k 2.0× 247 0.5× 38 3.7k
Matig Mavissakalian United States 36 2.1k 0.8× 1.8k 0.7× 411 0.6× 660 1.1× 252 0.6× 96 3.1k
Haggai Hermesh Israel 35 1.8k 0.7× 1.2k 0.5× 948 1.4× 1.2k 2.1× 325 0.7× 148 4.0k
R. Bruce Lydiard United States 33 1.6k 0.6× 1.6k 0.7× 614 0.9× 838 1.4× 442 1.0× 79 3.7k
Antoine Pélissolo France 33 1.9k 0.7× 1.2k 0.5× 902 1.3× 814 1.4× 157 0.3× 139 4.0k
Deborah Goetz United States 22 1.2k 0.5× 1.3k 0.5× 450 0.6× 479 0.8× 200 0.4× 36 2.4k
Eric Hollander United States 46 4.7k 1.8× 2.0k 0.8× 1.4k 2.0× 1.6k 2.7× 269 0.6× 130 6.1k
Scott Wetzler United States 33 1.6k 0.6× 984 0.4× 576 0.8× 910 1.6× 428 0.9× 77 3.9k
Manuel E. Tancer United States 33 1.2k 0.5× 1.4k 0.6× 1.2k 1.7× 499 0.9× 365 0.8× 79 3.7k
Eric Griez Netherlands 37 1.6k 0.6× 2.5k 1.0× 696 1.0× 648 1.1× 174 0.4× 133 3.9k

Countries citing papers authored by Raphael Campeas

Since Specialization
Citations

This map shows the geographic impact of Raphael Campeas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raphael Campeas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raphael Campeas more than expected).

Fields of papers citing papers by Raphael Campeas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raphael Campeas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raphael Campeas. The network helps show where Raphael Campeas may publish in the future.

Co-authorship network of co-authors of Raphael Campeas

This figure shows the co-authorship network connecting the top 25 collaborators of Raphael Campeas. A scholar is included among the top collaborators of Raphael Campeas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raphael Campeas. Raphael Campeas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schneier, Franklin R., et al.. (2017). A randomized controlled pilot trial of vilazodone for adult separation anxiety disorder. Depression and Anxiety. 34(12). 1085–1095. 17 indexed citations
2.
Simpson, H. Blair, Edna B. Foa, Michael R. Liebowitz, et al.. (2013). Cognitive-Behavioral Therapy vs Risperidone for Augmenting Serotonin Reuptake Inhibitors in Obsessive-Compulsive Disorder. JAMA Psychiatry. 70(11). 1190–1190. 153 indexed citations
3.
Blanco, Carlos, Richard G. Heimberg, Franklin R. Schneier, et al.. (2010). A Placebo-Controlled Trial of Phenelzine, Cognitive Behavioral Group Therapy, and Their Combination for Social Anxiety Disorder. Archives of General Psychiatry. 67(3). 286–286. 120 indexed citations
4.
Simpson, H. Blair, Edna B. Foa, Michael R. Liebowitz, et al.. (2008). A Randomized, Controlled Trial of Cognitive-Behavioral Therapy for Augmenting Pharmacotherapy in Obsessive-Compulsive Disorder. American Journal of Psychiatry. 165(5). 621–630. 187 indexed citations
5.
Simpson, H. Blair, Michael R. Liebowitz, Edna B. Foa, et al.. (2004). Post-treatment effects of exposure therapy and clomipramine in obsessive-compulsive disorder. Depression and Anxiety. 19(4). 225–233. 93 indexed citations
6.
Schneier, Franklin R., Carlos Blanco, Raphael Campeas, et al.. (2003). Citalopram treatment of social anxiety disorder with comorbid major depression. Depression and Anxiety. 17(4). 191–196. 42 indexed citations
7.
Marshall, Randall D., Franklin R. Schneier, Brian A. Fallon, et al.. (1998). An Open Trial of Paroxetine in Patients With Noncombat-Related, Chronic Posttraumatic Stress Disorder. Journal of Clinical Psychopharmacology. 18(1). 10–18. 119 indexed citations
8.
Fallon, Brian A., Michael R. Liebowitz, Raphael Campeas, et al.. (1998). Intravenous Clomipramine for Obsessive-Compulsive Disorder Refractory to Oral Clomipramine. Archives of General Psychiatry. 55(10). 918–918. 1 indexed citations
9.
Simpson, Blair, Franklin R. Schneier, Raphael Campeas, et al.. (1998). Imipramine in the Treatment of Social Phobia. Journal of Clinical Psychopharmacology. 18(2). 132–135. 71 indexed citations
10.
Heimberg, Richard G., Michael R. Liebowitz, Debra A. Hope, et al.. (1998). Cognitive Behavioral Group Therapy vs Phenelzine Therapy for Social Phobia. Archives of General Psychiatry. 55(12). 1133–1133. 398 indexed citations
11.
Fallon, Brian A., Michael R. Liebowitz, Raphael Campeas, et al.. (1998). Intravenous clomipramine for obsessive-compulsive disorder refractory to oral clomipramine: a placebo-controlled study.. PubMed. 55(10). 918–24. 80 indexed citations
12.
Papp, Laszlo A., Franklin R. Schneier, Abby J. Fyer, et al.. (1997). Clomipramine Treatment of Panic Disorder. The Journal of Clinical Psychiatry. 58(10). 423–425. 18 indexed citations
13.
Schneier, Franklin R., Robin Garfinkel, Raphael Campeas, et al.. (1996). Ondansetron in the treatment of panic disorder. PubMed. 2(4). 199–202. 18 indexed citations
14.
Liebowitz, Michael R., Jeremy D. Coplan, José Antônio Baddini Martínez, et al.. (1995). Effects of intravenous diazepam pretreatment on lactate-induced panic. Psychiatry Research. 58(2). 127–138. 8 indexed citations
15.
Liebowitz, Michael R., Franklin R. Schneier, Raphael Campeas, et al.. (1992). Phenelzine vs Atenolol in Social Phobia. Archives of General Psychiatry. 49(4). 290–290. 331 indexed citations
16.
Coplan, Jeremy D., Michael R. Liebowitz, Jack M. Gorman, et al.. (1992). Noradrenergic function in panic disorder effects of intravenous clonidine pretreatment on lactate induced panic. Biological Psychiatry. 31(2). 135–146. 22 indexed citations
17.
Liebowitz, Michael R., Eric Hollander, Raphael Campeas, et al.. (1990). Reversible and irreversible monoamine oxidase inhibitors in other psychiatric disorders. Acta Psychiatrica Scandinavica. 82(S360). 29–34. 48 indexed citations
18.
Liebowitz, Michael R., Eric Hollander, Franklin R. Schneier, et al.. (1990). Anxiety and Depression. Journal of Clinical Psychopharmacology. 10(Supplement). 61S–66S. 80 indexed citations
19.
Liebowitz, Michael R., Abby J. Fyer, Jack M. Gorman, et al.. (1988). Tricyclic therapy of the DSM-III anxiety disorders: A review with implications for further research. Journal of Psychiatric Research. 22. 7–31. 44 indexed citations
20.
Liebowitz, Michael R., Raphael Campeas, Andrew Levin, et al.. (1987). Pharmacotherapy of social phobia. Psychosomatics. 28(6). 305–308. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sharon Davies Breakdown of academic impact, for papers by Matig Mavissakalian Breakdown of academic impact, for papers by Haggai Hermesh Breakdown of academic impact, for papers by R. Bruce Lydiard Breakdown of academic impact, for papers by Antoine Pélissolo Breakdown of academic impact, for papers by Deborah Goetz Breakdown of academic impact, for papers by Eric Hollander Breakdown of academic impact, for papers by Scott Wetzler Breakdown of academic impact, for papers by Manuel E. Tancer Breakdown of academic impact, for papers by Eric Griez
Rankless by CCL
2026